From: Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
High-AEC (n = 73)
Low-AEC (n = 22)
P value
n
%
ORR
7
9.5
5
22.7
0.208a
DCR
47
64.3
14
63.6
0.949b